Re-Evaluating Adverse Reactions and Improving Drug
Children's Mercy has developed a Drug Safety Service that is
designed to more accurately define and describe adverse drug
reactions, side effects, allergies and idiosyncratic reactions.
Initiated as a pilot service to the General Pediatrics Teams, the
drug safety surveillance program is changing the way health care
personnel describe an adverse reaction.
Clinical pharmacists are re-evaluating historical reactions to
clarify what happened and determine whether the patient may safely
receive a medication in the future. This will expand the use of
trusted and cost-effective medications, when previously they may
have been denied based on inaccurate information. It also trains
staff to more clearly understand and define different types of
reactions and correctly document them. The Drug Safety Service will
expand to a hospital-wide program in early 2011 and begin utilizing
the 'trigger' system to recognize early adverse reactions that
occur within the institution.
Children's Mercy is also launching an inpatient consult service
to help children who are experiencing difficulties in prescribing
and utilizing specific medications. Physicians who collaborate
closely with the Clinical Pharmacology and Personalized Medicine
teams on a regular basis have created a list of medications for
which they would like support in the treatment of all types of
diseases and conditions. These will serve as pilot projects,
designed to work for other sub-specialists to improve care for
patients while also allowing providers throughout the system to be
involved in the development of programs that will utilize
information and technologies that are not currently available.
Click here to discover more ways
we're redefining pediatric medicine, one child at a time.